←Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma
Gilles Salles
MD, PhD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Chief, Lymphoma Service
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Gilles Salles chairs the lymphoma service at Memorial Sloan Kettering and has led multiple pivotal bispecific antibody trials including glofitamab and epcoritamab in DLBCL. He has contributed to establishing bispecifics as standard of care in relapsed aggressive lymphoma. His work has shaped international practice.
Share:
🧪Research Fields 研究领域
glofitamab
epcoritamab
bispecific antibodies
DLBCL
follicular lymphoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Gilles Salles 的研究动态
Follow Gilles Salles's research updates
留下邮箱，当我们发布与 Gilles Salles（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment